🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/06/2013 | 46,42 | 46,65 | 46,15 | 46,24 | +0,56% | 1,09% | 50.887.946 |
| 07/06/2013 | 46,54 | 46,89 | 45,90 | 45,98 | -0,84% | 2,13% | 52.852.631 |
| 06/06/2013 | 46,41 | 46,50 | 45,56 | 46,37 | -0,27% | 2,01% | 20.850.903 |
| 05/06/2013 | 46,77 | 47,45 | 46,25 | 46,50 | -1,44% | 2,57% | 26.119.409 |
| 04/06/2013 | 45,99 | 47,86 | 45,96 | 47,18 | +2,04% | 4,13% | 38.785.013 |
| 03/06/2013 | 46,69 | 47,10 | 46,10 | 46,23 | +3,75% | 2,15% | 39.805.450 |
| 31/05/2013 | 44,78 | 45,50 | 44,55 | 44,56 | -0,79% | 2,11% | 22.768.953 |
| 30/05/2013 | 44,87 | 45,22 | 44,60 | 44,91 | +0,43% | 1,38% | 15.933.268 |
| 29/05/2013 | 45,12 | 45,30 | 44,38 | 44,72 | -1,57% | 2,03% | 16.822.182 |
| 28/05/2013 | 45,74 | 46,41 | 45,34 | 45,44 | +0,98% | 2,34% | 18.511.767 |
| 24/05/2013 | 44,90 | 45,00 | 44,47 | 45,00 | -0,36% | 1,19% | 16.554.208 |
| 23/05/2013 | 44,33 | 45,27 | 44,29 | 45,16 | +1,33% | 2,20% | 23.663.421 |
| 22/05/2013 | 45,42 | 46,09 | 44,36 | 44,57 | -1,31% | 3,80% | 44.670.895 |
| 21/05/2013 | 43,17 | 45,35 | 43,12 | 45,16 | +4,69% | 5,17% | 49.277.694 |
| 20/05/2013 | 43,86 | 43,91 | 43,03 | 43,14 | -1,70% | 2,00% | 17.533.040 |
| 17/05/2013 | 44,17 | 44,57 | 43,02 | 43,88 | -0,82% | 3,52% | 22.773.459 |
| 16/05/2013 | 44,45 | 44,56 | 42,95 | 44,25 | -0,77% | 3,63% | 12.536.910 |
| 15/05/2013 | 44,59 | 45,10 | 44,33 | 44,59 | +0,17% | 1,71% | 13.831.294 |
| 14/05/2013 | 44,01 | 44,63 | 43,89 | 44,51 | +1,04% | 1,67% | 14.057.767 |
| 13/05/2013 | 43,74 | 44,11 | 43,59 | 44,06 | +0,48% | 1,20% | 10.738.018 |
| 10/05/2013 | 43,45 | 43,85 | 43,41 | 43,85 | +1,01% | 1,01% | 14.592.142 |
| 09/05/2013 | 43,18 | 43,53 | 42,89 | 43,41 | +1,11% | 1,48% | 14.856.134 |
| 08/05/2013 | 43,05 | 43,51 | 42,91 | 42,93 | -0,62% | 1,40% | 19.187.098 |
| 07/05/2013 | 43,03 | 43,23 | 42,82 | 43,20 | +0,64% | 0,93% | 15.226.078 |
| 06/05/2013 | 43,43 | 43,89 | 42,91 | 42,92 | -1,51% | 2,26% | 14.772.922 |
| 03/05/2013 | 44,13 | 44,26 | 43,38 | 43,58 | -0,13% | 1,99% | 13.492.581 |
| 02/05/2013 | 43,80 | 43,90 | 43,41 | 43,64 | +0,09% | 1,13% | 14.929.389 |
| 01/05/2013 | 42,75 | 44,19 | 42,56 | 43,60 | -2,79% | 3,82% | 41.648.358 |
| 30/04/2013 | 45,56 | 45,65 | 44,85 | 44,85 | -1,71% | 1,76% | 20.692.446 |
| 29/04/2013 | 45,69 | 45,92 | 45,53 | 45,63 | -0,10% | 0,84% | 11.921.943 |